Patent · US Active

PCV/Mycoplasma hyopneumoniae vaccine for use with PRRSV vaccine

US10668145B2 · kind B2 · utility

0Cited by

58References

28Claims

0Family size

Assignee

ZOETIS SERVICES LLC · US

Inventors

Gregory Paul Nitzel · Paw Paw, US
Jeffrey E. Galvin · Lincoln, US
John Keith Garrett · North Wilkesboro, US
James R. Kulawik, II · Lincoln, US
Tracy L. Ricker · Portage, US
Megan Marie Smutzer · Kalamazoo, US

Key dates

Filing date	Jan 15, 2019
Grant date	Jun 2, 2020
Priority date	—
Expiry date	Jan 15, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/10034
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides a combination of a first vaccine comprising a porcine circovirus type 2 (PCV2) antigen and a Mycoplasma hyopneumoniae (M. hyo) culture supernatant and a second vaccine comprising a porcine reproductive and respiratory syndrome (PRRS) virus antigen, for treating an animal against an infection with PCV2, an infection with M. hyo, and an infection with PRRS virus, wherein the M. hyo culture supernatant has been separated from insoluble cellular material and is substantially free of both IgG and immunocomplexes comprised of antigen bound to immunoglobulin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.